US: Lonza increases large-scale biologics manufacturing capacity with US acquisition

Lonza, a Switzerland-based global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has agreed to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Switzerland-based pharmaceutical […]